QCM
GMAB icon

Quantinno Capital Management’s Genmab GMAB Stock Holding History

Quantinno Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.58M Buy
282,498
+35,588
+14% +$1.07M 0.01% 976
2025
Q4 		$7.6M Buy
246,910
+37,075
+18% +$1.16M 0.02% 887
2025
Q3 		$6.44M Buy
209,835
+51,703
+33% +$1.26M 0.02% 831
2025
Q2 		$3.27M Buy
158,132
+62,226
+65% +$1.28M 0.01% 960
2025
Q1 		$1.88M Buy
95,906
+5,571
+6% +$117K 0.01% 998
2024
Q4 		$1.89M Buy
90,335
+66,128
+273% +$1.45M 0.02% 870
2024
Q3 		$590K Buy
24,207
+8,766
+57% +$234K 0.01% 1079
2024
Q2 		$388K Sell
15,441
-8,261
-35% -$234K 0.01% 1093
2024
Q1 		$709K Sell
23,702
-20,888
-47% -$614K 0.02% 850
2023
Q4 		$1.42M Buy
44,590
+28,038
+169% +$880K 0.05% 506
2023
Q3 		$584K Buy
16,552
+2,928
+21% +$112K 0.03% 686
2023
Q2 		$518K Buy
13,624
+1,766
+15% +$70.4K 0.03% 622
2023
Q1 		$448K Buy
11,858
+2,416
+26% +$92.9K 0.03% 616
2022
Q4 		$400K Buy
+9,442
New +$389K 0.03% 597

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Quantinno Capital Management's GMAB Position: Q1 2026 in Review

Quantinno Capital Management increased its Genmab (GMAB) stake by 14% in Q1 2026, buying an estimated $1.07M and bringing the position to 282,498 shares worth $7.58M. The position accounts for 0.01% of the portfolio, ranked #976.

Quantinno Capital Management first reported a position in GMAB in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.6M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Quantinno Capital Management held 282,498 shares of Genmab worth $7.58M as of Q1 2026.
  • Quantinno Capital Management bought 35,588 Genmab shares in Q1 2026, an estimated $1.07M.
  • Genmab made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #976 holding.
  • Quantinno Capital Management first reported a position in Genmab in Q4 2022 and has held it in 14 quarters since.
  • Quantinno Capital Management's Genmab position peaked at $7.6M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.